Tuas Biomedical Park (TBP) is a world-class manufacturing hub, hosting process development and manufacturing operations of major pharmaceutical, biotechnology and medical technology companies. Located at the western tip of Singapore, the TBP is only 60 minutes from Changi International Airport, 5 minutes from the Tuas Checkpoint to Malaysia and 20 minutes away from Jurong Port. The 312 ha TBP is strategically located to provide companies with access to skilled talent, research expertise, and air and sea logistics.
Leading global biomedical companies have invested in about 20 commercial-scale facilities in Singapore, which houses process development operations and manufacture of active pharmaceutical ingredients (APIs) and novel medicines. Both Pfizer and MSD GmbH have partnered Tuas Power, a leading Singapore based energy and utilities solutions provider, to develop state-of-the-art trigeneration facilities.
TBP is home to a host of global biomedical players, including GlaxoSmithKline, Lonza, MSD GmbH, Novartis, Pfizer and Roche.